Levels of toll-like receptors 2 and 4 in serum of men with postinfarction cardiosclerosis and its relationship with antiphospholipid syndrome components

  • M.S. Nazarova National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • M.A. Stanislavchuk National Pirogov Memorial Medical University, Vinnytsya, Ukraine
  • L.V. Burdeina National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: coronary heart disease, toll-like receptors, antiphospholipid syndrome.


Annotation. There is a tendency for an increase of incidence of coronary heart disease (CHD) among young people, with the development of acute myocardial infarction (MI) in the absence of marked atherosclerosis and obstruction of the coronary arteries. Antiphospholipid syndrome (APS), cellular and humoral mediators of immunoinflammatory activation of endothelium are considered as factors of non-obstructive damage to the coronary vessels. New trigger factors for endothelial dysfunction, cardiac fibrosis, and myocardial hypertrophy include toll-like receptors (TLR2 and TLR4). Antiphospholipid antibodies may act as endogenous activators of toll-like receptors. The study of the association between APS components and expression of toll-like receptors in patients with CHD with postinfarction cardiosclerosis remains relevant. The aim is to study the levels of TLR2 and TLR4 and its relationship with APS components in men with postinfarction cardiosclerosis. 164 patients with stable CHD with postinfarction cardiosclerosis (100% of men, age 53.0±9.14 years) and 48 men of control group (without CHD) were examined. Levels of total antiphospholipid antibodies (aPL), antibodies to β2-glycoprotein 1 (anti-β2-GP 1) IgG and IgM, TLR2, TLR4 in serum were determined by ELISA. The studies were conducted in compliance with bioethical standards. Statistical processing of the results was performed in SPSS Statistics 22.0. Determined that men with postinfarction cardiosclerosis showed higher levels of TLR2 and TLR4 (in 1.8–2.2 times, p<0.001) in serum than control group. Higher (in 1.2–1.4 times) levels of TLR2 and TLR4 were found in patients who underwent Q-MI, recurrent MI and had clinical manifestations of APS (stroke, transient ischemic attacks, livedo reticularis). An increase TLR2 and TLR4 levels was closely associated with an increase of aPL and anti-β2-GP 1 of IgG (r = | 0.31 - 0.51 |, p<0.01). Thus, in men with postinfarction cardiosclerosis who had aPL and anti-β2-GP 1 IgG positivity had an unfavorable immunoinflammatory pattern, that characterized by increased expression of TLR2 and TLR4. The imbalance in TLR2 and TLR4 is more pronounced in young CHD patients and associated with Q-MI and recurrent MI.


1. Benhamou, Y., Bellien, J., Armengol, G., Brakenhielm, E., Adriouch, S., Iacob, M., … Joannidès, R. (2014). Role of Toll-like receptors 2 and 4 in mediating endothelial dysfunction and arterial remodeling in primary arterial antiphospholipid syndrome. Arthritis Rheumatol., 66(11), 3210–3220. doi: 10.1002/art.38785.

2. Caimi, G., Montana, M., Andolina, G., Hopps, E., & Lo Presti, R. (2019). Plasma Viscosity and NLR in Young Subjects with Myocardial Infarction: Evaluation at the Initial Stage and at 3 and 12 Months. Clin. Med. Insights Cardiol., 13, 1179546819849428. doi: 10.1177/1179546819849428.

3. Chen, H., Li, M., Liu, L., Dang, X., Zhu, D., & Tian, G. (2019). Monocyte/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients with non-ST-elevation myocardial infarction. Medicine, 98(26), 1–10. doi: 10.1097/MD.0000000000016267.

4. Colasanti, T., Alessandri, C., Capozzi, A., Sorice, M., Delunardo, F., Longo, A., … Margutti, P. (2012). Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood, 120(16), 3360–3370. doi: 10.1182/blood-2011-09-378851.

5. Franck, G., Mawson, T., Sausen, G., Salinas, M., Masson, G. S., Cole, A., … Libby, P. (2017). Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion. Circ. Res., 121(1), 31–42. doi: 10.1161/CIRCRESAHA.117.310694.

6. Hjort, M., Eggers, K. M., Lindhagen, L., Agewall, S., Brolin, E. B., Collste, O., … Lindahl, B. (2019). Increased Inflammatory Activity in Patients 3 Months after Myocardial Infarction with Nonobstructive Coronary Arteries. Clin. Chem., 65(8), 1023–1030. doi: 10.1373/clinchem.2018.301085.

7. Huang, Z., Liu, Y., Liang, L., Liu, W., Sooranna, S. R., Mo, J., … Guo, J. (2019). Correlation between coronary stenosis and Toll-like receptors 2 and 4 levels in Chinese Zhuang patients with coronary heart disease. Exp. Ther. Med., 18(3), 2346–2352. doi: 10.3892/etm.2019.7805.

8. Meroni, P. L., Raschi, E., Testoni, C., Parisio, A., & Borghi, M. O. (2004). Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun Rev., 3(7–8), 510–515. DOI: 10.1016/j.autrev.2004.07.007.

9. Miyakis, S., Lockshin, M. D., Atsumi, T., Branch, D. W., Brey, R. L., Cervera, R., … Krilis, S. A. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost., 4(2), 295–306. DOI: 10.1111/j.1538-7836.2006.01753.x.

10. Pierangeli, S. S., Vega-Ostertag, M. E., Raschi, E., Liu, X., Romay-Penabad, Z., De Micheli, V., … Meroni, P. L. (2007) Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann. Rheum. Dis., 66(10), 1327–1333. DOI: 10.1136/ard.2006.065037.

11. Quillard, T., Araújo, H. A., Franck, G., Shvartz, E., Sukhova, G., & Libby, P. (2015). TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. Eur. Heart J., 36(22), 1394–1404. doi: 10.1093/eurheartj/ehv044.

12. Quillard, T., Franck, G., Mawson, T., Folco, E., & Libby, P. (2017). Mechanisms of erosion of atherosclerotic plaques. Curr. Opin. Lipidol., 28(5), 434–441. doi: 10.1097/MOL.0000000000000440.

13. Raschi, E., Borghi, M. O., Grossi, C., Broggini, V., Pierangeli, S., & Meroni, P. L. (2008). Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus, 17(10), 938–943. doi: 10.1177/0961203308095140.

14. Raschi, E., Testoni, C., Bosisio, D., Borghi, M. O., Koike, T., Mantovani, A., & Meroni, P. L. (2003). Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood, 101(9), 3495–3500. DOI: 10.1182/blood-2002-08-2349.

15. Salvador, B., Arranz, A., Francisco, S., Córdoba, L., Punzón, C., Llamas, M. Á., & Fresno, M. (2016). Modulation of endothelial function by Toll like receptors. Pharmacol. Res., 108, 46–56. doi: 10.1016/j.phrs.2016.03.038.

16. Satta, N., Dunoyer-Geindre, S., Reber, G., Fish, R. J., Boehlen, F., Kruithof, E. K., & de Moerloose, P. (2007). The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood, 109(4), 1507–1514. DOI: 10.1182/blood-2005-03-024463.

17. Satta, N., Kruithof, E. K., Fickentscher, C., Dunoyer-Geindre, S., Boehlen, F., Reber, G., … de Moerloose P. (2011). Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood, 117(20), 5523–5531. doi: 10.1182/blood-2010-11-316158.

18. Stepien, K., Nowak, K., Wypasek, E., Zalewski, J., & Undas, A. (2019). High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke. Int. J. Card., 290, 1–6. doi: 10.1016/j.ijcard.2019.05.037.

19. Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., … Ward, M. M. (2019). EULAR recommendations for the management of antiphospholipid syndrome in adults. Annals of the Rheumatic Diseases, 78(10), 1296–1304. doi: 10.1136/annrheumdis-2019-215213.

20. Timmers, L., Sluijter, J. P., van Keulen, J. K., Hoefer, I. E., Nederhoff, M. G., Goumans, M. J., … de Kleijn, D. P. V. (2008). Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ. Res., 102, 257–264. DOI: 10.1161/CIRCRESAHA.107.158220.

21. Trentin-Sonoda, M., da Silva, R. C., Kmit, F. V., Abrahão, M. V., Monnerat Cahli, G., Brasil, G. V., ... Carneiro-Ramos, M. S. (2015). Knockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice. PLoS One, 10, 0139350. doi: 10.1371/journal.pone.0139350.

22. Wang, H., Zhang, N., Li, G., & Xu, B. (2019). Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease. Life Sci., 231, 116510. doi: 10.1016/j.lfs.2019.05.066.

23. Wang, Y., Chen, L., Tian, Z., Shen, X., Wang X., Wu H., ... Liang, J. (2018). CRISPR-Cas9 mediated gene knockout in human coronary artery endothelial cells reveals a pro-inflammatory role of TLR2. Cell Biol Int., 42(2), 187–193. doi: 10.1002/cbin.10885.
How to Cite
Nazarova, M., Stanislavchuk, M., & Burdeina, L. (2019). Levels of toll-like receptors 2 and 4 in serum of men with postinfarction cardiosclerosis and its relationship with antiphospholipid syndrome components. Reports of Vinnytsia National Medical University, 23(4), 599-604. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2019-23(4)-07